IGF-1 LR3
Tissue-targeted growth signaling.
An 83–amino-acid synthetic IGF-1 analog with extended half-life — engineered to drive protein synthesis, muscle and bone regeneration, and MUSCLE BONE TISSUE
Growth signaling, extended.
A modified IGF-1 analog with 20–30 hour half-life that binds IGF-1 receptors in muscle and bone — supporting protein synthesis and recovery.
- Athletes pursuing performance and recovery optimization
- Patients in muscle-wasting recovery contexts
- Anyone managing post-injury or strength-rebuilding programs
Lean Muscle Growth
Promotes muscle cell growth and differentiation. Muscle building and definition accelerate.
Recovery & Repair
Accelerates muscle fiber and connective tissue repair. Training adaptation and healing improve.
Nutrient Partitioning
Improves how the body directs nutrients. Body uses nutrients more efficiently.
Bone & Joint Support
Supports collagen synthesis and bone density. Structural integrity strengthens.
Recovery in Muscle-Wasting States
Useful in recovery from injury and clinical wasting. Clinical recovery accelerates.
Training capacity and recovery feel stronger.
Visible muscle and strength changes emerge.
Sustained body composition and capacity gains.
- Physician-supervised by Thomas Nabity, MD
- 503A / 503B compounding pharmacy sourcing
- Pre-protocol labs, body composition, and review
- 30 / 60 / 90-day follow-up with companion support